connecticut medicaid glp-1 weight loss coverage 2025 Weight-loss drug tests employers' health plan budgets Connecticut is moving to eliminate

Physicians share the five most common emotional impacts they consider before prescribing GLP-1 drugs to adolescents.

Overcoming access challenges with transitional assistance The market access environment for new launch products has become progressively restrictive with payers enforcing more prior authorizations, step edits, and blocks than ever before

A patient experiencing significant tachycardia while on tirzepatide should discontinue the medication immediately if they have postural orthostatic tachycard...

Pancreatitis history raises important questions about GLP-1 therapy safety

Discover the essential safety considerations, monitoring requirements, and medical guidance for combining thyroid medication with GLP-1 treatments like Wegovy and Saxenda in the UK.

18, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health, today announced a free tier of its acclaimed wellness app and introduced Rebel Wilson as its Chief Wellness Ambassador